Researcher
Jan Cools
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Hematology, Cancer biology
- See also: Cools J (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Molecular Biology of Leukemia (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2008 → Today - Laboratory of Molecular Biology of Leukemia (VIB-KU Leuven) (Division)
Member
From1 Dec 2017 → Today - Cools Lab (Research group)
Responsible
From1 Jan 2017 → Today - Faculty of Medicine (Faculty)
Member
From1 Oct 2004 → 30 Sep 2005 - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 30 Nov 2017
Projects
41 - 50 of 62
- Study of the tumor suppressor function of CNOT3 in Tcell acute lymphoblastic leukemia.From12 Nov 2012 → 21 Nov 2019Funding: FWO fellowships
- Identification of coding and non-coding cancer drivers from whole-genome re-sequencing data using gene regulatory network analysis.From1 Oct 2012 → 23 Feb 2018Funding: IWT personal funding - strategic basic research grants
- The JAK3 kinase as a therapeutic target in T-cell acute lymphoblastic leukemia.From1 Sep 2012 → 31 Dec 2017Funding: IWT personal funding - strategic basic research grants
- The role of ribosomal defects in cancer.From1 Sep 2012 → 23 Mar 2017Funding: IWT personal funding - strategic basic research grants
- PACBIO.From26 Apr 2012 → 1 Nov 2018Funding: Hercules - Large scale research infrastructure
- Role of the hedgehog pathway in the development of T-cell aculte lymphoblastic leukemia.From1 Jan 2012 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Characterization of the tyrosine phosphatase gene PTPRD and its role in the development of leukemia.From1 Oct 2011 → 30 Sep 2012Funding: Other federal public and semi-governmental institutions
- Discovery and prioritization of gene regulatory modules driving oncogenesis.From1 Oct 2011 → 30 Sep 2014Funding: FWO fellowships
- Role of the tyrosine phosphatase PTPN2 in the development of leukemia.From1 Sep 2011 → 31 Aug 2012Funding: Other federal public and semi-governmental institutions
- From individual cancer genes to integrated cancer pathways in childhood cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 200
- Single cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome(2024)
Authors: Emilie Pollenus, Sofie Demeyer, Jan Cools, Gianluca Matteoli, Jeroen Vanoirbeek, Greetje Vande Velde, Philippe Van den Steen
- Identification of novel targets for treatment in T-cell acute lymphoblastic leukemia(2023)
Authors: Inge Govaerts, Jan Cools
- CRISPR screening in hematology research: from bulk to single-cell level(2023)
Authors: Sarah Meyers, Sofie Demeyer, Jan Cools
- Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia(2023)
Authors: Charlien Vandersmissen, David Nittner, Johan Maertens, Heidi Segers, Jan Cools
Pages: 2507 - 2512 - Targeting STAT5B in T-cell acute lymphoblastic leukemia(2023)
Authors: Jan Cools
Pages: 215 - 217 - Primary mediastinal large B-cell lymphoma is hallmarked by large-scale copy-neutral loss of heterozygosity(2023)
Authors: Jonas Demeulemeester, Lucienne Michaux, Jan Cools, Thomas Tousseyn
Pages: 525 - 525 - Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Authors: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pages: 1862 - 1878 - A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling(2023)
Authors: Ginevra Doglioni, Alex Cuadros, Xiaozheng Liu, dorien Broekaert, Sofie Demeyer, Xander Spotbeen, Margherita Demicco, François Richard, Tatjana Geukens, Maxim De Schepper, et al.
Pages: 344 - + - Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma(2022)
Authors: Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, David Nittner, Thomas Tousseyn, Jan Cools, Daan Dierickx
Pages: 2463 - 2476 - Genetic drivers of peripheral T-cell lymphomagenesis(2022)
Authors: Koen Debackere, Daan Dierickx, Gregor Verhoef, Jan Cools
Patents
1 - 2 of 2